Dennis Matheis - 08 May 2024 Form 4 Insider Report for Lucid Diagnostics Inc. (LUCD)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LUCD	Employee stock option (right to buy)	Award	$0	+241,500		$0.000000	241,500	08 May 2024	Common stock	241,500	$1.03	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	One third of the option vests on December 31, 2024; the balance vests in eight equal quarterly installments, starting March 31, 2025.